Not Signed In - [ Disclaimer: The information on GoldBamboo for any particular treatment, medicine, drug, or herbal product might be missing or incomplete, and should never be used as a single source of knowledge. GoldBamboo generally has links to authoritative sites displayed toward the bottom of each topic page under the heading "Resources". ]
Prednisolone Ophthalmic |
AK-Pred; Econopred; Econopred Plus; Inflamase Forte; Inflamase Mild; Pred Forte; Pred Mild |
Clinical Trial: Phase IV study of TRAVATAN 0.004% in subjects with iris pigmentation changes
This study is currently recruiting patients.
|
Purpose
To monitor iris pigmentation changes over a five year period in subjects with open-angle glaucoma or ocular hypertension who have experienced an iris pigmentation change while dosing with TRAVATAN.
| Condition | Treatment or Intervention | Phase |
|---|---|---|
| Open-Angle Glaucoma Ocular Hypertension | Drug: TRAVATAN (travoprost ophthalmic solution) 0.004% | Phase IV |
MedlinePlus related topics: Eye Diseases; Glaucoma
Study Type: Interventional
Study Design: Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Safety Study
Official Title: A Phase IV safety study of TRAVATAN 0.004% in subjects with TRAVATAN induced iris pigmentation changes C-01-79.
Eligibility
Genders Eligible for Study: Both
Criteria
Subjects of any race and of either sex diagnosed with open-angle glaucoma (with or without pseudoexfoliation or pigment dispersion component) or ocular hypertension who have experienced an iris pigmentation change while dosing with TRAVATAN and who are currently using TRAVATAN
Location and Contact Information
Alcon Call Center 1-888-451-EYES (3937) alconlabs.com
Texas
Alcon Call Center For Locations, Multiple Cities & Multiple States, Texas, United States; Recruiting
More Information
Study ID Numbers: C-01-79; C-01-79
Record last reviewed: June 2003
Last Updated: October 13, 2004
Record first received: October 8, 2002
ClinicalTrials.gov Identifier: NCT00047554
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-04-08
Record last reviewed: June 2003
Last Updated: October 13, 2004
Record first received: October 8, 2002
ClinicalTrials.gov Identifier: NCT00047554
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 9, 2005
email this page
print this page
bookmark this page
feedback on this page
